Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.
Monoclonal antibodies (MAbs) were obtained by immunizing mice with synthetic peptides corresponding to the third variable (V3) or the third conserved (C3) domain of the external envelope protein (gp120) of human immunodeficiency virus type 2 (HIV-2ROD). One MAb, designated B2C, which was raised agai...
Na minha lista:
| 發表在: | J Virol |
|---|---|
| Principais autores: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
1995
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC189045/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7538171/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.69.6.3333-3340.1995 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|
